Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood.

Inter-individual DNA methylation variations were frequently hypothesized to alter individual susceptibility to Type 2 Diabetes Mellitus (T2DM). Sequence-influenced methylations were described in T2DM-associated genomic regions, but evidence for direct, sequence-independent association with disease risk is missing. Here, we explore disease-contributing DNA methylation through a stepwise study design: first, a pool-based, genome-scale screen among 1169 case and control individuals revealed an excess of differentially methylated sites in genomic regions that were previously associated with T2DM through genetic studies. Next, in-depth analyses were performed at selected top-ranking regions. A CpG site in the first intron of the FTO gene showed small (3.35%) but significant (P = 0.000021) hypomethylation of cases relative to controls. The effect was independent of the sequence polymorphism in the region and persists among individuals carrying the sequence-risk alleles. The odds of belonging to the T2DM group increased by 6.1% for every 1% decrease in methylation (OR = 1.061, 95% CI: 1.032-1.090), the odds ratio for decrease of 1 standard deviation of methylation (adjusted to gender) was 1.5856 (95% CI: 1.2824-1.9606) and the sensitivity (area under the curve = 0.638, 95% CI: 0.586-0.690; males = 0.675, females = 0.609) was better than that of the strongest known sequence variant. Furthermore, a prospective study in an independent population cohort revealed significant hypomethylation of young individuals that later progressed to T2DM, relative to the individuals who stayed healthy. Further genomic analysis revealed co-localization with gene enhancers and with binding sites for methylation-sensitive transcriptional regulators. The data showed that low methylation level at the analyzed sites is an early marker of T2DM and suggests a novel mechanism by which early-onset, inter-individual methylation variation at isolated non-promoter genomic sites predisposes to T2DM.

[1]  F. Watt,et al.  Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. , 1988, Genes & development.

[2]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[3]  Ian M. Morison,et al.  Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus , 2010, PloS one.

[4]  A. Chess,et al.  Extensive sequence-influenced DNA methylation polymorphism in the human genome , 2010, Epigenetics & Chromatin.

[5]  D. Aran,et al.  Replication timing-related and gene body-specific methylation of active human genes. , 2011, Human molecular genetics.

[6]  I. Weissman,et al.  Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[7]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[8]  E. Flemington,et al.  CpG methylation as a mechanism for the regulation of E2F activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Balding,et al.  Epigenome-wide association studies for common human diseases , 2011, Nature Reviews Genetics.

[10]  R. T. Lie,et al.  FTO, Type 2 Diabetes, and Weight Gain Throughout Adult Life , 2011, Diabetes.

[11]  B. Tycko,et al.  Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation , 2008, Nature Genetics.

[12]  T. Mikkelsen,et al.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.

[13]  R. Plomin,et al.  Allelic skewing of DNA methylation is widespread across the genome. , 2010, American journal of human genetics.

[14]  C. Gieger,et al.  Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 Genes Confer Risk of Type 2 Diabetes Independently of BMI in the German KORA Studies , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  R. Plomin,et al.  DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. , 2010, Methods.

[16]  D. Siscovick,et al.  Birth weight of offspring, maternal pre-pregnancy characteristics, and mortality of mothers: the Jerusalem perinatal study cohort. , 2009, Annals of epidemiology.

[17]  Madeleine P. Ball,et al.  Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells , 2009, Nature Biotechnology.

[18]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[19]  Mark I McCarthy,et al.  Type 2 diabetes: new genes, new understanding. , 2008, Trends in genetics : TIG.

[20]  Ugo Boggi,et al.  Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals. , 2009, Journal of proteome research.

[21]  R. Plomin,et al.  Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation , 2009, Epigenetics & Chromatin.

[22]  Andrew P Feinberg,et al.  An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.

[23]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[24]  G. Prendergast,et al.  Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. , 1991, Science.

[25]  A. Verhoeven,et al.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2 , 2008, Diabetologia.

[26]  M. Bonke,et al.  Chromatin "Prepattern" and Histone Modifiers in a Fate Choice for Liver and Pancreas , 2011 .

[27]  G. Luc,et al.  Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. , 2000, Atherosclerosis.

[28]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[29]  Mark I. McCarthy,et al.  Assessing the Combined Impact of 18 Common Genetic Variants of Modest Effect Sizes on Type 2 Diabetes Risk , 2008, Diabetes.

[30]  Albert Jeltsch,et al.  BISMA - Fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences , 2010, BMC Bioinformatics.

[31]  A. Mortazavi,et al.  Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.

[32]  Daniel F. Gudbjartsson,et al.  Parental origin of sequence variants associated with complex diseases , 2009, Nature.

[33]  Arturas Petronis,et al.  Epigenetics as a unifying principle in the aetiology of complex traits and diseases , 2010, Nature.

[34]  Hei Sook Sul,et al.  A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin , 2009, Cell.

[35]  Holger Karas,et al.  TRANSFAC: a database on transcription factors and their DNA binding sites , 1996, Nucleic Acids Res..

[36]  S. Vaulont,et al.  Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose* , 1998, The Journal of Biological Chemistry.

[37]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[38]  J. Bressler,et al.  Risk of Type 2 Diabetes and Obesity Is Differentially Associated with Variation in FTO in Whites and African-Americans in the ARIC Study , 2010, PloS one.

[39]  J. Eeckhoute,et al.  Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. , 2011, Genome research.

[40]  P. Jacques,et al.  Plasma Homocysteine and Parental Myocardial Infarction in Young Adults in Jerusalem , 2002, Circulation.

[41]  Jonathan Schug,et al.  The Nucleosome Map of the Mammalian Liver , 2011, Nature Structural &Molecular Biology.

[42]  Lee E. Edsall,et al.  Human DNA methylomes at base resolution show widespread epigenomic differences , 2009, Nature.

[43]  Ina Ruck,et al.  USA , 1969, The Lancet.

[44]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Chess,et al.  Gene Body-Specific Methylation on the Active X Chromosome , 2007, Science.

[46]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .